Trial · NCT03371355
Adverse events116
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 116
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Injection site pruritus | General disorders | Pooled Placebo | 0 | 27 | |
| other | Injection site pruritus | General disorders | Cohort B: ISIS 703802, 40 mg Q4W | 1 | 26 | |
| other | Injection site pruritus | General disorders | Cohort C: ISIS 703802, 80 mg Q4W | 8 | 26 | |
| other | Injection site pruritus | General disorders | Cohort A: ISIS 703802, 20 mg QW | 2 | 26 | |
| other | Injection site erythema | General disorders | Pooled Placebo | 0 | 27 | |
| other | Injection site erythema | General disorders | Cohort B: ISIS 703802, 40 mg Q4W | 1 | 26 | |
| other | Injection site erythema | General disorders | Cohort C: ISIS 703802, 80 mg Q4W | 6 | 26 | |
| other | Injection site erythema | General disorders | Cohort A: ISIS 703802, 20 mg QW | 2 | 26 | |
| other | Pyrexia | General disorders | Pooled Placebo | 0 | 27 | |
| other | Pyrexia | General disorders | Cohort B: ISIS 703802, 40 mg Q4W | 0 | 26 | |
| other | Pyrexia | General disorders | Cohort C: ISIS 703802, 80 mg Q4W | 2 | 26 | |
| other | Pyrexia | General disorders | Cohort A: ISIS 703802, 20 mg QW | 0 | 26 | |
| other | Pharyngitis | Infections and infestations | Pooled Placebo | 0 | 27 | |
| other | Pharyngitis | Infections and infestations | Cohort B: ISIS 703802, 40 mg Q4W | 2 | 26 | |
| other | Pharyngitis | Infections and infestations | Cohort C: ISIS 703802, 80 mg Q4W | 3 | 26 | |
| other | Pharyngitis | Infections and infestations | Cohort A: ISIS 703802, 20 mg QW | 1 | 26 | |
| other | Nasopharyngitis | Infections and infestations | Pooled Placebo | 0 | 27 | |
| other | Nasopharyngitis | Infections and infestations | Cohort B: ISIS 703802, 40 mg Q4W | 1 | 26 | |
| other | Nasopharyngitis | Infections and infestations | Cohort C: ISIS 703802, 80 mg Q4W | 3 | 26 | |
| other | Nasopharyngitis | Infections and infestations | Cohort A: ISIS 703802, 20 mg QW | 1 | 26 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03371355/events